Biodesix Inc. (BDSX) Tops Q2 EPS by 19c
Tweet
Share
E-mailGet Alerts BDSX Hot Sheet
Join SI Premium – FREE
Biodesix Inc. (NASDAQ: BDSX) reported Q2 EPS of ($0.71), $0.19 better than the analyst estimate of ($0.90). Revenue for the quarter came in at $26.9 million versus the consensus estimate of $25.96 million.
For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Morgan Stanley sees limited gas regulation impact on utilities
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recover
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
